Provided by Tiger Trade Technology Pte. Ltd.

Alamar Biosciences

34.24
-0.4000-1.15%
Post-market: 34.00-0.2400-0.70%18:47 EDT
Volume:212.39K
Turnover:7.43M
Market Cap:2.37B
PE:-47.82
High:36.10
Open:34.93
Low:34.14
Close:34.64
52wk High:38.54
52wk Low:18.85
Shares:69.31M
Float Shares:12.94M
Volume Ratio:0.69
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7160
EPS(LYR):-2.5873
ROE:-33.57%
ROA:-13.53%
PB:7.59
PE(LYR):-13.23

Loading ...

Alzpath: Broadens Strategic Agreement with Alamar Biosciences to Advance Clinical Diagnostics for Alzheimer's Disease

THOMSON REUTERS
·
Jul 23

Alamar Biosciences Director Ian Ratcliffe Dies; Board Size Reduced to Five

Reuters
·
Jul 16

Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026

GlobeNewswire
·
Jul 15

BofA Securities Adjusts Alamar Biosciences Price Target to $30 From $27

MT Newswires Live
·
Jul 13

Alamar teams with research universities to launch proteomics initiatives

TIPRANKS
·
Jul 13

Alamar Biosciences Launches National Blood Biomarker Initiative for Alzheimer’s Research

Reuters
·
Jul 13

Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling

GlobeNewswire
·
Jul 10

Alamar Biosciences Launches First Multiplexed Blood-based Immunoassay for Emtbr-tau, One of Most Important Biomarkers in Alzheimer's Disease Research

THOMSON REUTERS
·
Jul 07

Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research

GlobeNewswire
·
Jul 07

Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX)

TIPRANKS
·
Jun 09

Alamar Biosciences initiated with an Outperform at Leerink

TIPRANKS
·
May 13

BofA Initiates Alamar Biosciences at Neutral With $27 Price Target

MT Newswires Live
·
May 12

Alamar Biosciences, Inc. : Bofa Global Research Initiates Coverage With Neutral Rating and Price Objective $27.00

THOMSON REUTERS
·
May 12

Stifel Initiates Alamar Biosciences at Buy With $28 Price Target

MT Newswires Live
·
May 12

Alamar Biosciences Initiated at Buy by Stifel

Dow Jones
·
May 12

Alamar Biosciences Inc : TD Cowen Initiates Coverage With Buy Rating; Price Target $30

THOMSON REUTERS
·
May 12

Alamar Biosciences Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $35

THOMSON REUTERS
·
May 12

Alamar Biosciences initiated with a Buy at TD Cowen

TIPRANKS
·
May 12

Alamar Biosciences initiated with an Overweight at JPMorgan

TIPRANKS
·
May 12

Alamar Biosciences initiated with a Buy at Stifel

TIPRANKS
·
May 12